UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 成人におけるカンジダ菌血症および侵襲性カンジダ症 treatment of candidemia and invasive candidiasis in adults
- 2. 成人におけるカンジダ菌血症の疫学および病因 epidemiology and pathogenesis of candidemia in adults
- 3. 新生児におけるカンジダ感染の疫学および危険因子 epidemiology and risk factors for candida infection in neonates
- 4. 新生児におけるカンジダ感染の治療 treatment of candida infection in neonates
- 5. カンジダ感染症の生物学 biology of candida infections
English Journal
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J.SourceVirginia Commonwealth University Medical Center, Richmond, Virginia, USA.
- Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2013 Dec;57(12):5836-42. doi: 10.1128/AAC.01519-13. Epub 2013 Sep 9.
- Although Clinical and Laboratory Standards Institute (CLSI) clinical breakpoints (CBPs) are available for interpreting echinocandin MICs for Candida spp., epidemiologic cutoff values (ECVs) based on collective MIC data from multiple laboratories have not been defined. While collating CLSI caspofungi
- PMID 24018263
- Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex.
- Abi-Chacra EA, Souza LO, Cruz LP, Braga-Silva LA, Gonçalves DS, Sodré CL, Ribeiro MD, Seabra SH, Figueiredo-Carvalho MH, Barbedo LS, Zancopé-Oliveira RM, Ziccardi M, Santos AL.SourceLaboratório de Investigação de Peptidases (LIP), Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes (IMPG), Centro de Ciências da Saúde (CCS), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- FEMS yeast research.FEMS Yeast Res.2013 Dec;13(8):831-48. doi: 10.1111/1567-1364.12092. Epub 2013 Oct 25.
- The production of virulence attributes in three reference strains and 11 clinical isolates primarily identified as Candida parapsilosis was evaluated. Morphological and phenotypical tests were not able to discriminate among the three species of the C. parapsilosis complex; consequently, molecular m
- PMID 24103069
- Invasive candidiasis in pediatric intensive care in Greece: a nationwide study.
- Vogiatzi L, Ilia S, Sideri G, Vagelakoudi E, Vassilopoulou M, Sdougka M, Briassoulis G, Papadatos I, Kalabalikis P, Sianidou L, Roilides E.SourcePICU, Hippokration Hospital, Thessaloniki, Greece.
- Intensive care medicine.Intensive Care Med.2013 Dec;39(12):2188-95. doi: 10.1007/s00134-013-3057-y. Epub 2013 Aug 14.
- PURPOSE: To record the practices for prevention and management of invasive candidiasis in the PICU and investigate the epidemiology of candidiasis and its outcome nationwide.METHODS: A multicenter national study among PICUs throughout Greece. A questionnaire referring to local practices of preventio
- PMID 23942859
Japanese Journal
- Antifungal Susceptibility of <I>Candida</I> Isolates at One Institution
- Katsuragi Shinji,Sata Makoto,Kobayashi Yoshinari,Miyoshi Takekazu,Yamashita Yasuki,Neki Reiko,Horiuchi Chinami,Yamanaka Kaoru,Kamiya Chizuko,Iwanaga Naoko,Tanaka Hiroaki,Ikeda Tomoaki,Yoshimatsu Jun
- Medical Mycology Journal 55(1), E1-E7, 2014
- … 20.3%, <I>Candida parapsilosis</I> … parapsilosis</I>, <I>C. … parapsilosis</I> … parapsilosis</I>, and micafungin showed good efficacy against <I>C. …
- NAID 130003397211
- カンジダ血流感染症に対するミカファンギンの投与量と有効性に関する検討
- 菅原 隆文,村上 礼隆,植竹 宣江,松本 俊治,宮森 伸一,岡本 良一,開 浩一
- YAKUGAKU ZASSHI 134(3), 433-438, 2014
- … Among all patients, the efficacy rate of micafungin was found to be lower in patients infected by Candida parapsilosis as compared to those infected by other Candida species. … However, among the patients who received ≥100 mg/d of micafungin, the efficacy rate in patients infected by Candida parapsilosis was equivalent to that of patients who were infected by other Candida species. …
- NAID 130003391185
- De Novo Design of Non-coordinating Indolones as Potential Inhibitors for Lanosterol 14-α-Demethylase (CYP51)
- Gonzalez-Chavez Rodolfo,Martinez Roberto,Torre-Bouscoulet Maria Eugenia [他],Gallo Marco,González-Chávez Marco Martín
- Chemical and Pharmaceutical Bulletin 62(1), 16-24, 2014
- … Nearly all tested compounds 8a–g displayed activity against Candida tropicalis, Candida guilliermondii and Candida parapsilosis with a minimum inhibitory concentration (MIC) value until 8 µg mL−1, on the other hand compounds 7a–g showed activity against Aspergillus fumigatus with a MIC value of 31.25 µg mL−1. …
- NAID 130003381800
Related Links
- はじめまして。私は、東大阪市にありますIVF大阪クリニックの當仲（とうなか）と申します。当クリニックは、不妊症治療専門のクリニックで体外受精を主に行っております。実は、お恥ずかしい話ですが、先日培養液の中に何か菌のような ...
- [Home][Japanese Cover][English Cover] Pathogenic Fungi Database (PFDB) Candida parapsilosis Synonym:Candida parapsilosis var. intermedia Please link to Home! [Bottom][Colony][Photomicrography][Clinical Feature][Pathology][DNA ...
- Candida parapsilosis. 6 likes. Candida parapsilosis is a fungal species of the yeast family that has become a significant cause of sepsis and of wound and tissue infections in immuno-compromised patients. The immune system is a ...
Related Pictures
